Literature DB >> 14935257

BACTERIA at the sea bottom.

.   

Abstract

Keywords:  BACTERIA

Mesh:

Year:  1952        PMID: 14935257      PMCID: PMC2023801     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Triethylene melamine therapy in Hodgkin's and other malignant diseases.

Authors:  P B HANSEN; J BICHEL
Journal:  Acta radiol       Date:  1951-12       Impact factor: 1.990

2.  Clinical observations on the use of triethylenemelamine.

Authors:  E D BAYRD; J M STICKNEY; B E HALL; C H WATKINS
Journal:  Cancer       Date:  1952-03       Impact factor: 6.860

3.  Use of triethylene melamine in treatment of leukemia and leukosarcoma.

Authors:  J H SILVERBERG; W DAMESHEK
Journal:  J Am Med Assoc       Date:  1952-03-22

4.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

5.  The nitrogen mustard-like actions of 2,4,6-tris (ethylenimino)-s-triazine and other bis(ethylenimines).

Authors:  F S PHILIPS; J B THIERSCH
Journal:  J Pharmacol Exp Ther       Date:  1950-12       Impact factor: 4.030

6.  Nitrogen mustard therapy in the reticuloses.

Authors:  J D N NABARRO
Journal:  Br J Radiol       Date:  1951-09       Impact factor: 3.039

7.  Triaethyleneimino-s-triazine in human malignant disease: a preliminary trial.

Authors:  E PATERSON; J BOLAND
Journal:  Br J Cancer       Date:  1951-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.